Gufic Biosciences (NSE:GUFICBIO) Minority Interest: ₹0.38 Mil (As of Mar. 2026)


NSE:GUFICBIO Gufic Biosciences Ltd NSE:GUFICBIO
75 GF Score
Price ₹370.25
GF Value ₹405.66
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Gufic Biosciences Minority Interest?

Gufic Biosciences NSE:GUFICBIO +2.73% 75 Minority Interest is ₹0.38 Mil as of Mar. 2026. GuruFocus rates NSE:GUFICBIO with a GF Score™ of 75/100 and a GF Value™ of ₹405.66 (Fairly Valued). The stock has 6 warning signs investors should review.

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Gufic Biosciences's minority interest for the quarter that ended in Mar. 2026 was ₹0.38 Mil.

Gufic Biosciences Minority Interest Historical Data

* Premium members only.

The historical data trend for Gufic Biosciences's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gufic Biosciences Minority Interest Chart

Gufic Biosciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Minority Interest
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.38

Gufic Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Minority Interest Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.35 0.00 0.38
NSE:GUFICBIO
75GF Score
Gufic Biosciences Ltd NSE:GUFICBIO
Minority Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gufic Biosciences Minority Interest Calculation

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Frequently Asked Questions Learn more about Minority Interest →
What does a Minority Interest of ₹0.38 Mil mean?
Gufic Biosciences (NSE:GUFICBIO) has a Minority Interest of ₹0.38 Mil as of Mar. 2026. Minority interest represents the carrying value of equity from non-controlling shareholders and company partners. View historical data on Gufic Biosciences.
Is Gufic Biosciences' Minority Interest too high?
Gufic Biosciences' current Minority Interest is ₹0.38 Mil. Overall, Gufic Biosciences has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gufic Biosciences' Minority Interest compare to ZTS?
Gufic Biosciences' Minority Interest of ₹0.38 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Minority Interest for a Drug Manufacturers company?
A good Minority Interest depends on the Drug Manufacturers industry context. However, Minority Interest should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Minority Interest mean?
A high Minority Interest can signal that a stock is expensive relative to its fundamentals. Minority interest represents the carrying value of equity from non-controlling shareholders and company partners. View historical data on Gufic Biosciences. Gufic Biosciences's current Minority Interest is ₹0.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gufic Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Gufic Biosciences (NSE:GUFICBIO) is currently considered Fairly Valued. The stock's GF Value™ is ₹405.66, compared to a current price of ₹370.25 — trading 8.7% below its estimated fair value. The current Minority Interest is ₹0.38 Mil. Gufic Biosciences' overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Minority Interest calculated?
Minority Interest is calculated from a company's financial statements. For Gufic Biosciences (NSE:GUFICBIO), the current Minority Interest is ₹0.38 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gufic Biosciences (NSE:GUFICBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Gufic Biosciences stock appears to be undervalued. The current stock price of ₹370.25 is trading 8.7% below its estimated GF Value™ of ₹405.66. GuruFocus considers Gufic Biosciences to be Fairly Valued.

Key valuation signals for NSE:GUFICBIO:

  • Minority Interest: ₹0.38 Mil
  • GF Value™: ₹405.66 vs. price of ₹370.25 (8.7% below fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the NSE:GUFICBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gufic Biosciences Business Description

Other Exchanges 509079:India
Address SM House, 11 Sahakar Road, 1st to 4th Floor, Vile Parle (East), Mumbai, MH, IND, 400 057
Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare, Criticare Life, Ferticare, Spark, Herbal, and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral, and a proton-pump inhibitor. It derives maximum revenue from India.
75GF Score

Get the complete analysis for NSE:GUFICBIO

Minority Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹370.25
Price
₹405.66
GF Value